Dita Gratzinger

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi Update on Myelodysplastic Syndromes Classification and Prognosis
    Dita Gratzinger
    Department of Pathology, Stanford University Medical Center, 300 Pasteur Drive, L235, Stanford, CA 94305, USA Electronic address
    Surg Pathol Clin 6:693-728. 2013
  2. pmc Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes
    Dita Gratzinger
    Department of Pathology, Stanford University, Stanford, California, Stanford, CA 94305 5324, USA
    Am J Pathol 170:1362-9. 2007
  3. doi Ameloblastoma, calcifying epithelial odontogenic tumor, and glandular odontogenic cyst show a distinctive immunophenotype with some myoepithelial antigen expression
    Dita Gratzinger
    Department of Surgical Pathology, Stanford University School of Medicine, Stanford, CA 94305 5324, USA
    J Oral Pathol Med 37:177-84. 2008
  4. pmc Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP)
    Dita Gratzinger
    Department of Pathology, Stanford University School of Medicine, CA 94305 5324, USA
    Br J Haematol 148:235-44. 2010
  5. ncbi LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab
    Yasodha Natkunam
    Department of Pathology, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA
    J Clin Oncol 26:447-54. 2008
  6. pmc The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities
    Dita Gratzinger
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305 5324, USA
    Am J Clin Pathol 131:264-78. 2009
  7. pmc CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas
    Robert F Luo
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Hum Pathol 41:271-80. 2010
  8. ncbi Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy
    Dita Gratzinger
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305 5324, USA
    Lab Invest 88:38-47. 2008
  9. ncbi Identification of the regions of PECAM-1 involved in beta- and gamma-catenin associations
    Purba Biswas
    Department of Pathology, Yale University School of Medicine, New Haven, CT, USA
    Biochem Biophys Res Commun 329:1225-33. 2005
  10. ncbi Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho
    Dita Gratzinger
    Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    FASEB J 17:1458-69. 2003

Detail Information

Publications18

  1. doi Update on Myelodysplastic Syndromes Classification and Prognosis
    Dita Gratzinger
    Department of Pathology, Stanford University Medical Center, 300 Pasteur Drive, L235, Stanford, CA 94305, USA Electronic address
    Surg Pathol Clin 6:693-728. 2013
    ..With the advent of deep sequencing technologies, dozens of molecular abnormalities have been identified in MDS. ..
  2. pmc Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes
    Dita Gratzinger
    Department of Pathology, Stanford University, Stanford, California, Stanford, CA 94305 5324, USA
    Am J Pathol 170:1362-9. 2007
    ..These differences may have important implications for the responsiveness of the two diffuse large B-cell lymphoma subtypes to anti-vascular endothelial growth factor and anti-angiogenic therapies...
  3. doi Ameloblastoma, calcifying epithelial odontogenic tumor, and glandular odontogenic cyst show a distinctive immunophenotype with some myoepithelial antigen expression
    Dita Gratzinger
    Department of Surgical Pathology, Stanford University School of Medicine, Stanford, CA 94305 5324, USA
    J Oral Pathol Med 37:177-84. 2008
    ..In the 1980s, an ultrastructural study identified a population of myoepithelial-like cells in calcifying epithelial odontogenic tumor. Myoepithelial derived tumors have since been shown to have distinct immunohistochemical profiles...
  4. pmc Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP)
    Dita Gratzinger
    Department of Pathology, Stanford University School of Medicine, CA 94305 5324, USA
    Br J Haematol 148:235-44. 2010
    ..In contrast to our prior results with chemotherapy alone, microvessel density was not prognostic of PFS or OS with R-CHOP-like therapy...
  5. ncbi LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab
    Yasodha Natkunam
    Department of Pathology, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA
    J Clin Oncol 26:447-54. 2008
    ..Here, we tested the prognostic impact of LMO2 protein expression in DLBCL patients treated with anthracycline-based chemotherapy with or without rituximab...
  6. pmc The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities
    Dita Gratzinger
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305 5324, USA
    Am J Clin Pathol 131:264-78. 2009
    ..The restricted expression pattern, nuclear localization, and crisp staining of LMO2 in paraffin blocks make it an attractive candidate for the diagnostic immunohistochemistry laboratory...
  7. pmc CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas
    Robert F Luo
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Hum Pathol 41:271-80. 2010
    ....
  8. ncbi Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy
    Dita Gratzinger
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305 5324, USA
    Lab Invest 88:38-47. 2008
    ..Dependence on autocrine vascular endothelial growth factor receptor-1-mediated signaling may render a subset of diffuse large B-cell lymphomas susceptible to anthracycline-based therapy...
  9. ncbi Identification of the regions of PECAM-1 involved in beta- and gamma-catenin associations
    Purba Biswas
    Department of Pathology, Yale University School of Medicine, New Haven, CT, USA
    Biochem Biophys Res Commun 329:1225-33. 2005
    ....
  10. ncbi Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho
    Dita Gratzinger
    Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    FASEB J 17:1458-69. 2003
    ..PECAM-1 may thus support the effective S1P/RhoGTP signaling required for wound healing endothelial migration by allowing for the spatially directed, coordinated activation of Galpha signaling pathways...
  11. doi Intravascular ALK-negative anaplastic large cell lymphoma with localized cutaneous involvement and an indolent clinical course: toward recognition of a distinct clinicopathologic entity
    Ryan A Metcalf
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Am J Surg Pathol 37:617-23. 2013
    ....
  12. doi Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma
    Sebastian Fernandez-Pol
    Department of Pathology, Stanford University, Stanford, CA, 94305, 5324 Electronic address
    Hum Pathol 55:39-43. 2016
    ..Testing for an IGH/BCL2 translocation should be considered in the diagnostic workup of difficult-to-characterize neoplasms with histiocytic/monocytic morphology and immunoprofile. ..
  13. doi Lymph node involvement by mycosis fungoides and S├ęzary syndrome mimicking angioimmunoblastic T-cell lymphoma
    Robert E LeBlanc
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305
    Hum Pathol 46:1382-9. 2015
    ....
  14. pmc Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications
    Grant E Nybakken
    Department of Pathology, Stanford University School of Medicine, Stanford, California, 94305, United States of America
    PLoS ONE 11:e0151735. 2016
    ..Differentiating such cases from follicular lymphoma or another mimic is critical, lest patients with indolent proliferations be exposed to unnecessarily aggressive treatment. ..
  15. doi Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival
    Ryan C Johnson
    From the Department of Pathology, Stanford University School of Medicine, Stanford, CA, and
    Am J Clin Pathol 142:795-802. 2014
    ..We retrospectively tested the prognostic and diagnostic significance of CD271+ mesenchymal stromal cell (MSC) density in cytopenic patients who underwent bone marrow biopsy to evaluate for myelodysplastic syndromes (MDS)...
  16. doi Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma
    Dita Gratzinger
    Departments of Pathology, Radiation Oncology, and Dermatology, Stanford University School of Medicine, Stanford, CA
    Am J Dermatopathol 37:767-70. 2015
    ....
  17. pmc In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
    Youn H Kim
    Department of Dermatology, Stanford University School of Medicine, CA, USA
    Blood 119:355-63. 2012
    ..This study is registered at www.clinicaltrials.gov as NCT00226993...
  18. pmc Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2
    Josephine M Enciso
    Department of Pathology, Yale University School of Medicine, New Haven, CT 06520 8023, USA
    J Cell Biol 160:605-15. 2003
    ....